Trulieve Cannabis Corp. · OTC:TCNNF

Trulieve Cannabis — Q1 2022 Earnings Presentation

27 slides from Trulieve Cannabis's earnings presentation, May 12, 2022

  1. Slide 1: First Quarter 2022 Investor Presentation

    First Quarter 2022 Investor Presentation / May 2022 CSE: TRUL OTCQX: TCNNF Exhibit 99.2

  2. Slide 2: Forward Looking Statements and Industry Data

    Forward Looking Statements and Industry Data Unless the context otherwise requires, the terms “Trulieve,” “we,” “us” and “our” in this presentation refer to Trulieve Cannabis Corp. and its subsidiaries. Certain statements in this presentation constitute forward-looking statements within the meaning

  3. Slide 3: Management's Use of Non-GAAP Financial Measures

    Management’s Use of Non-GAAP Financial Measures In addition to our results determined in accordance with GAAP, we supplement our results with non-GAAP financial measures, including adjusted gross profit, adjusted net income, adjusted net income per diluted share, and adjusted cash flow from operatio

  4. Slide 4: Agenda

    Agenda First Quarter 2022 Financial Highlights First Quarter 2022 Operational Highlights Financial Outlook Recent Developments Strategic Priorities Financial Results

  5. Slide 5: First Quarter 2022 Financial Highlights

    First Quarter 2022 Financial Highlights* Revenue increased 64% year-over-year and 4% sequentially to $318.3 million Gross profit of $178.2 million and gross margin of 56.0% in the first quarter of 2022 compared to gross profit of $132.4 million and gross margin of 43.4% in the fourth quarter 2021 Ne

  6. Slide 6: First Quarter 2022 Financial Highlights

    First Quarter 2022 Financial Highlights* *Adjusted EBITDA is a Non-GAAP financial measure. See slides 24-26 for reconciliation to GAAP for all Non-GAAP financial measures.

  7. Slide 7: First Quarter 2022 Operational Highlights

    First Quarter 2022 Operational Highlights Trulieve opened 3 new dispensaries in Boca Raton and Riverview, Florida and Philadelphia, Pennsylvania Production in Q1 2022 was 9.8 million units, up 91% year over year Trulieve acquired 64k square feet of operational indoor cultivation capacity in Arizona

  8. Slide 8: Financial Outlook

    Financial Outlook Reiterating Full Year 2022 Guidance Revenue of $1.3 billion to $1.4 billion Adjusted EBITDA of $450 million to $500 million Open 25-30 new dispensaries, relocate up to 6 dispensaries in Florida Anticipate 2H:22 results will reflect improved performance as strategic initiatives driv

  9. Slide 9: Recent Developments

    Recent Developments Achieved record revenue, units sold, and number of customers served on 4/20 holiday Launched “4.20 For All” NFT collection Launched adult use sales at Napa, California dispensary Announced new brand partnership with DeLisioso Brands in Florida Expanded brand partnership with Khal

  10. Slide 10: Growth Initiatives

    Growth Initiatives

  11. Slide 11: Strategic Priorities

    Strategic Priorities Deliver Exceptional Customer Experiences and Build Brand Loyalty Provide superb service, expedient transactions, and frictionless returns Innovate across product and consumer categories Expand through Hub Strategy Invest in cornerstone markets: Florida, Pennsylvania, and Arizona

  12. Slide 12: Customer Experience and Brand Loyalty

    Customer Experience and Brand Loyalty Customer Experience Service, convenience, frictionless returns Customer loyalty rewards High quality products, broad selection New and innovative products Clones (MA only) Refined Crème, TruTonic powdered drink mix, and TruWax Live Budder, Live Diamonds, Live Me

  13. Slide 13: Regional Hubs: Cultivation, Processing, Retail Capacity

    Regional Hubs: Cultivation, Processing, Retail Capacity FL CA MA PA AZ MD WV NV AZ CO CT GA 165 Stores As of May 12, 2022 All stores owned, operated, or affiliated >4.0 M ft2 Cultivation & Processing As of March 31, 2022 Operational Arizona California Colorado Connecticut Florida Massachusetts Maryl

  14. Slide 14: Cornerstone Markets: Florida, Pennsylvania, Arizona

    Cornerstone Markets: Florida, Pennsylvania, Arizona Limited license markets Leading market presence in retail Cultivation, processing and manufacturing operations Potential for expansion and optimization Potential future catalysts with adult use expansion in Florida and Pennsylvania Fast and favorab

  15. Slide 15: Cornerstone Market: Florida

    Cornerstone Market: Florida Limited License Medical Market Trulieve operates 115 medical dispensaries Florida market has 22 vertical licenses issued and 428 approved dispensaries as of May 6, 2022 Cultivation and processing capacity expansion is ongoing Increasing production of differentiated produc

  16. Slide 16: Cornerstone Market: Pennsylvania

    Cornerstone Market: Pennsylvania Limited License Medical Market 19 affiliated retail locations Pennsylvania market has 50 retail permits (3 locations per permit), 25 grower/processor licenses, and up to 10 research/clinical permits Ongoing expansion of indoor cultivation and processing capacity thro

  17. Slide 17: Cornerstone Market: Arizona

    Cornerstone Market: Arizona Limited License Adult Use and Medical Market Trulieve operates 17 retail dispensaries Arizona market has 131 core vertical licenses, 13 rural/underserved county licenses, and 26 future social equity licenses Expansion of cultivation and processing ongoing Plan to open two

  18. Slide 18: Distribution of Branded Products through Branded Retail and Wholesale Channels

    Distribution of Branded Products through Branded Retail and Wholesale Channels Trulieve Brands VALUE MID PREMIUM

  19. Slide 19: Distribution of Branded Products: Partner Brands

    Distribution of Branded Products through Branded Retail and Wholesale Channels Partner Brands

  20. Slide 20: Financials

    Financials

  21. Slide 21: Transaction Related and Non-Recurring Charges

    Transaction Related and Non-Recurring Charges Transaction related charges $0.4 million fair value of inventory step up charge $17.2 million transaction, acquisition, integration, and other non-recurring charges $13.8 million in asset impairments associated with the closing of redundant cultivation f

  22. Slide 22: Financial Highlights

    Financial Highlights* *Adjusted Gross Profit, Adjusted Net Income, and Adjusted EBITDA are Non-GAAP financial measures. See slides 24-26 for reconciliation to GAAP for all Non-GAAP financial measures.

  23. Slide 23: Financial Highlights: Balance Sheet and Share Count

    www trulieve.com Financial Highlights BALANCE SHEET HIGHLIGHTS (USD millions) Q1:22 Q4:21 Q3:21 Q2:21 Q1:21 4:20 Cash 267 234 214 289 162 147 Debt 553 479 137 137 136 135 SHARE COUNT ESTIMATE (millions as of March 31, 2022 on as if converted basis) Subordinate Voting Shares 35.0 Multiple Voting Shar

  24. Slide 24: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures

  25. Slide 25: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures

  26. Slide 26: Reconciliation of Non-GAAP Financial Measures

    Reconciliation of Non-GAAP Financial Measures

  27. Slide 27: Thank You

    Thank You CSE: TRUL OTCQX: TCNNF @Trulieve/@Trulieve_IR ir@trulieve.com

Trulieve Cannabis — Q1 2022 Earnings Presentation on 6ix